adenosine diphosphate ribose has been researched along with GS-441524 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altincekic, N; Argyriou, AI; Elamri, I; Fourkiotis, NK; Gallo, A; Gande, SL; Krishnathas, R; Linhard, V; Löhr, F; Richter, C; Rogov, VV; Schwalbe, H; Spyroulias, GA; Sreeramulu, S; Tsika, AC; Weiss, MS; Wollenhaupt, J | 1 |
| Anmangandla, A; Bagde, SR; Drown, BS; Fromme, JC; Hergenrother, PJ; Jana, S; Lin, H; Peng, K; Wallace, SD; Xu, J | 1 |
2 other study(ies) available for adenosine diphosphate ribose and GS-441524
| Article | Year |
|---|---|
Binding Adaptation of GS-441524 Diversifies Macro Domains and Downregulates SARS-CoV-2 de-MARylation Capacity.
Topics: Adenosine; Adenosine Diphosphate Ribose; ADP-Ribosylation; Coronavirus Protease Inhibitors; Humans; Poly(ADP-ribose) Polymerases; Protein Binding; Protein Domains; SARS-CoV-2 | 2022 |
A Fluorescence Polarization Assay for Macrodomains Facilitates the Identification of Potent Inhibitors of the SARS-CoV-2 Macrodomain.
Topics: Adenosine Diphosphate; Adenosine Diphosphate Ribose; COVID-19; Fluorescence Polarization; Humans; SARS-CoV-2 | 2023 |